Remote Jobs at Verastem Oncology

Verastem Oncology

51 - 200 employees

Founded 2010

🧬 Biotechnology

💊 Pharmaceuticals

Biotechnology • Pharmaceuticals

Verastem Oncology is a clinical-stage biopharmaceutical company focused on developing novel small-molecule therapies that target the RAS/MAPK signaling pathway to treat aggressive and recurrent cancers. The company develops and advances combination therapies, including RAF/MEK clamp and FAK inhibitors (e. g. , avutometinib and defactinib), and has an FDA-approved combination for KRAS-mutant recurrent low-grade serous ovarian cancer. Verastem runs multiple clinical trials, collaborates strategically, and centers its pipeline on inhibiting RAS-driven tumor biology to improve patient outcomes.